PMID- 20639902 OWN - NLM STAT- MEDLINE DCOM- 20101027 LR - 20211020 IS - 1476-5594 (Electronic) IS - 0950-9232 (Print) IS - 0950-9232 (Linking) VI - 29 IP - 39 DP - 2010 Sep 30 TI - Lung cancer cell migration is regulated via repressing growth factor PTN/RPTP beta/zeta signaling by menin. PG - 5416-26 LID - 10.1038/onc.2010.282 [doi] AB - Menin encoded by the multiple endocrine neoplasia type 1 (MEN1) gene is associated with chromatin and the nuclear matrix and exerts multiple biological functions including regulation of cell proliferation and adhesion. Men1 mutations increase the likelihood of lung cancer development in mice. Menin expression is reduced in certain human non-small cell lung cancer cells, and reduction of menin is closely correlated with increased lung cancer metastasis to lymph nodes. However, it is poorly understood whether menin affects migration of lung cancer cells. In this study, we show that menin-regulated A549 lung cancer cell migration, which was mediated by growth factor pleiotrophin (PTN) and its cell surface receptor, protein tyrosine phosphatase beta/zeta (RPTP beta/zeta). Ectopic menin expression significantly repressed PTN transcription, but indirectly inhibited RPTP beta/zeta expression through repressing PTN expression. Further studies revealed that menin-regulated cell migration through PTN/RPTP beta/zeta, in conjunction with integrin alpha(v)beta(3), focal adhesion kinase, phosphatidylinositol 3-kinase and phosphorylated extracellular signal regulated kinase 1/2. These findings provide mechanistic insights into the molecular basis for menin/PTN-mediated regulation of A549 lung cancer cell migration. FAU - Feng, Z-J AU - Feng ZJ AD - Department of Basic Medical Sciences, Medical College, Xiamen University, Xiamen, Fujian, PR China. FAU - Gao, S-B AU - Gao SB FAU - Wu, Y AU - Wu Y FAU - Xu, X-F AU - Xu XF FAU - Hua, X AU - Hua X FAU - Jin, G-H AU - Jin GH LA - eng GR - R01 CA113962/CA/NCI NIH HHS/United States GR - R01 DK097555/DK/NIDDK NIH HHS/United States GR - R01CA113962/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20100719 PL - England TA - Oncogene JT - Oncogene JID - 8711562 RN - 0 (Carrier Proteins) RN - 0 (Cytokines) RN - 0 (Integrin alphaVbeta3) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (MEN1 protein, human) RN - 0 (Proto-Oncogene Proteins) RN - 134034-50-7 (pleiotrophin) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - EC 3.1.3.48 (Protein Tyrosine Phosphatases) RN - EC 3.1.3.48 (Receptor-Like Protein Tyrosine Phosphatases, Class 5) SB - IM MH - Carrier Proteins/*metabolism MH - Cell Movement/genetics/*physiology MH - Cytokines/*metabolism MH - Humans MH - Integrin alphaVbeta3/genetics/metabolism MH - Intercellular Signaling Peptides and Proteins/genetics/metabolism MH - Lung Neoplasms/*genetics MH - Phosphatidylinositol 3-Kinases/genetics/metabolism MH - Phosphorylation MH - Protein Tyrosine Phosphatases/genetics/*metabolism MH - Proto-Oncogene Proteins/*physiology MH - Receptor-Like Protein Tyrosine Phosphatases, Class 5/*metabolism MH - Signal Transduction/genetics/*physiology PMC - PMC3007126 EDAT- 2010/07/20 06:00 MHDA- 2010/10/28 06:00 CRDT- 2010/07/20 06:00 PHST- 2010/07/20 06:00 [entrez] PHST- 2010/07/20 06:00 [pubmed] PHST- 2010/10/28 06:00 [medline] AID - onc2010282 [pii] AID - 10.1038/onc.2010.282 [doi] PST - ppublish SO - Oncogene. 2010 Sep 30;29(39):5416-26. doi: 10.1038/onc.2010.282. Epub 2010 Jul 19.